CTNNB1 genotyping and APC screening in pediatric desmoid tumors: A proposed algorithm

Pediatric and Developmental Pathology

Volumn 15, Issue 5, 2012, Pages 361-367

  Wang, Wei Lien ^a   Nero, Christopher ^b   Pappo, Alberto ^c   Lev, Dina ^a   Lazar, Alexander J ^a   López Terrada, Dolores ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c St Jude Children's Research Hospital   (United States)

Author keywords

APC; Beta catenin; CTNNB1; Desmoid; Pediatric; Wnt

Indexed keywords

APC PROTEIN; BETA CATENIN;

ADENOMATOUS POLYP; ALGORITHM; ARTICLE; CANCER SCREENING; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CTNNB1 GENE; DESMOID TUMOR; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; GERM LINE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SOMATIC MUTATION;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ALGORITHMS; BETA CATENIN; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROMATOSIS, AGGRESSIVE; GENES, APC; GENETIC TESTING; GENOTYPE; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84870030455     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/11-07-1064-OA.1     Document Type: Article

References (40)

1. Weiss SR, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors, 5th ed. Philadelphia: Mosby Elsevier, 2008.
2. Goldblum JR, Fletcher JA. Desmoid-Fibromatosis. Volume 2002. Lyon: IARC Press, 2002.
3. Lazar AJ, Hajibashi S, Lev D. Desmoid tumor: from surgical extirpation to molecular dissection. Curr Opin Oncol 2009;21:352-359.
4. Bertario L, Russo A, Sala P, et al. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 2001;95:102-107. (Pubitemid 32187081)
5. Nieuwenhuis MH, De Vos Tot Nederveen Cappel W, Botma A, et al. Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol 2008;6:215-219. (Pubitemid 351172943)
6. Gurbuz AK, Giardiello FM, Petersen GM, et al. Desmoid tumours in familial adenomatous polyposis. Gut 1994;35:377-381. (Pubitemid 24092910)
7. Clark SK, Smith TG, Katz DE, Reznek RH, Phillips RK. Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis. Br J Surg 1998;85: 970-973. (Pubitemid 28341571)
8. Sen-Gupta S, Van der Luijt RB, Bowles LV, Meera Khan P, Delhanty JD. Somatic mutation of APC gene in desmoid tumour in familial adenomatous polyposis. Lancet 1993;342:552-553. (Pubitemid 23259201)
9. Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 1997;151: 329-334. (Pubitemid 27330053)
10. Li C, Bapat B, Alman BA. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol 1998;153:709-714. (Pubitemid 28419025)
11. Miyoshi Y, Iwao K, Nawa G, Yoshikawa H, Ochi T, Nakamura Y. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res 1998; 10:591-594. (Pubitemid 128740447)
12. Tejpar S, Michils G, Denys H, et al. Analysis of Wnt/beta catenin signalling in desmoid tumors. Acta Gastroenterol Belg 2005;68:5-9. (Pubitemid 40477417)
13. Jilong Y, Jian W, Xiaoyan Z, Xiaoqiu L, Xiongzeng Z. Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis. Pathology 2007;39:319-325. (Pubitemid 46897606)
14. Kotiligam D, Lazar AJ, Pollock RE, Lev D. Desmoid tumor: a disease opportune for molecular insights. Histol Histopathol 2008; 23:117-126.
15. Barker N. The canonical Wnt/beta-catenin signalling pathway. Methods Mol Biol 2008;468:5-15.
16. Lazar AJ, Tuvin D, Hajibashi S, et al. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 2008;173:1518-1527.
17. Amary MF, Pauwels P, Meulemans E, et al. Detection of betacatenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Am J Surg Pathol 2007; 31:1299-1309. (Pubitemid 47329665)
18. Lips DJ, Barker N, Clevers H, Hennipman A. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors). Eur J Surg Oncol 2009;35:3-10.
19. Baba S, Ando H, Nakamura Y. Identification of germ line mutation of APC gene in possible carriers of familial adenomatous polyposis (FAP). Anticancer Res 1994;14:2189-2192.
20. Montgomery E, Folpe AL. The diagnostic value of beta-catenin immunohistochemistry. Adv Anat Pathol 2005;12:350-356.
21. Carlson JW, Fletcher CD. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Histopathology 2007;51:509-514. (Pubitemid 47437826)
22. Thway K, Gibson S, Ramsay A, Sebire NJ. Beta-catenin expression in pediatric fibroblastic and myofibroblastic lesions: a study of 100 cases. Pediatr Dev Pathol 2009;12:292-296.
23. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 2005;29:653-659. (Pubitemid 40577876)
24. Bo N, Wang D, Wu B, Chen L, Ma R. Analysis of beta-catenin expression and exon 3 mutations in pediatric sporadic aggressive fibromatosis. Pediatr Dev Pathol 2012;15:173-178.
25. Tejpar S, Nollet F, Li C, et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 1999;18:6615-6620.
26. Abraham SC, Reynolds C, Lee JH, et al. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway. Hum Pathol 2002;33:39-46. (Pubitemid 34112951)
27. Saito T, Oda Y, Kawaguchi K, et al. Possible association between higher beta-catenin mRNA expression and mutated beta-catenin in sporadic desmoid tumors: real-time semiquantitative assay by TaqMan polymerase chain reaction. Lab Invest 2002;82:97-103. (Pubitemid 34072650)
28. Domont J, Salas S, Lacroix L, et al. High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management. Br J Cancer102:1032-1036.
29. Jarvinen HJ, Peltomaki P. The complex genotype-phenotype relationship in familial adenomatous polyposis. Eur J Gastroenterol Hepatol 2004;16:5-8. (Pubitemid 39043696)
30. Nieuwenhuis MH, Vasen HF. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol 2007;61:153-161. (Pubitemid 46073779)
31. Sturt NJ, Gallagher MC, Bassett P, et al. Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 2004; 53:1832-1836. (Pubitemid 39556906)
32. Nieuwenhuis MH, Casparie M, Mathus-Vliegen LM, Dekkers OM, Hogendoorn PC, Vasen HF. A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses. Int J Cancer 2011;129:256-261.
33. Eccles D, Harvey J, Bateman A, Ross F. A novel 3′ mutation in the APC gene in a family presenting with a desmoid tumour. J Med Genet 2001;38:861-863. (Pubitemid 34014212)
34. Eccles DM, van der Luijt R, Breukel C, et al. Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. Am J Hum Genet 1996;59:1193-1201. (Pubitemid 26394110)
35. Giarola M, Wells D, Mondini P, et al. Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours. Br J Cancer 1998;78:582-587. (Pubitemid 28375588)
36. Jarvinen HJ. Desmoid disease as a part of familial adenomatous polyposis coli. Acta Chir Scand 1987;153:379-383.
37. Giarola M, Stagi L, Presciuttini S, et al. Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: evidence for phenotypic differences in cases with and without identified mutation. Hum Mutat 1999;13:116-123. (Pubitemid 29059150)
38. Coffin CM, Hornick JL, Zhou H, Fletcher CD. Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas. Am J Surg Pathol 2007;31:410-416. (Pubitemid 46673115)
39. Wehrli BM, Weiss SW, Yandow S, Coffin CM. Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis. Am J Surg Pathol 2001;25:645-651. (Pubitemid 32423363)
40. Brueckl WM, Ballhausen WG, Fortsch T, et al. Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma. Dis Colon Rectum 2005;48:1275-1281. (Pubitemid 40897876)